Projects per year
Personal profile
Education
- 2000-2007 M.D., School of Medicine, National Cheng Kung University
Experience
- Director, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- Attending Physician, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2018.06- Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2010.08-2012.07 Chief Resident Physician, Linkou Chang Gung Memorial Hospital
- 2007.08-2010.07 Resident Physician, Linkou Chang Gung Memorial Hospital
Fingerprint
Dive into the research topics where Chia-Lun Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
雙打擊在瀰漫大B細胞淋巴瘤所扮演的角色-致病機轉與臨床特色之探討-MCL1蛋白在雙打擊瀰漫大B細胞淋巴瘤的表現及其臨床的角色
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
Research output
-
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells
Liao, C. H., Yong, C. Y., Lai, G. M., Chow, J. M., Cheng, C. F., Fang, C. L., Lin, P. C., Chang, C. L., Zheng, Y. M., Chuang, S. E., Whang-Peng, J. & Yao, C. J., 2020, (Accepted/In press) In: American Journal of Chinese Medicine. 48, 6, p. 1491-1509 19 p.Research output: Contribution to journal › Article › peer-review
-
Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells
Liao, C. H., Tzeng, Y. T., Lai, G. M., Chang, C. L., Hu, M. H., Tsai, W. L., Liu, Y. R., Hsia, S., Chuang, S. E., Chiou, T. J., Wang, L. M., Whang-Peng, J. & Yao, C. J., Jul 29 2020, In: Marine Drugs. 18, 8, 399.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Outcomes of adjuvant oral versus intravenous fluoropyrimidines for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Zhang, J., Yen, Y. C., Qin, L., Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Jan 1 2020, In: Journal of Cancer. 11, 14, p. 4157-4165 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Subcutaneous Panniculitis Like T Cell Lymphoma Complicated With Hemophagocytic Lymphohistiocytosis - A Challenging Case Report
Zheng, Y. M., Chang, C., Hu, M-H., Chao, H-M., Whang-Peng, J., Lai, G-M. & Chiou, T-J., Jan 1 2020, In: Archives of Clinical and Medical Case Reports. 04Research output: Contribution to journal › Article › peer-review
-
Adjuvant therapy for high-risk stage ii or iii colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Dec 2019, In: Cancers. 11, 12, 2003.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)